Press Releases
Ceapro Inc. to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Ceapro Inc. Reports 2021 Second Quarter and Six-Month Financial Results and Operational Highlights
Ceapro Inc. Enters into Research Collaboration with the Angiogenesis Foundation for Beta Glucan and Avenanthramides
Ceapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, Avenanthramide
Ceapro Announces Results of 2021 Shareholders’ Meeting
Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent
Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights
Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta
